A Name-Brand Cough Syrup Was Just Recalled Nationwide
Updated: Jan. 24, 2024
The FDA urges consumers not to ingest these potentially contaminated medications marketed to treat severe cough, flu and sore throat.
As colds, flu, and COVID-19 diagnoses persist in these wintry months, an over-the-counter product may help see you or a loved one through the worst of the illness. However, if Robitussin is a medication you rely on, on January 24, 2024 its manufacturer announced recalled three products you may want to check your cabinet for.
Haleon, the company that produces and distributes brand-name health and wellness products like Robitussin, has just recalled eight lots of cough syrup for potential “microbial contamination,” according to an alert by the Food and Drug Administration (FDA). The source and type of microbes weren’t specified and it seems no illnesses due to the contamination concern have been reported to date. The products are labeled to contain true source-certified honey.
The affected medicines are the brand’s Robitussin Honey CF Max Day and Robitussin Honey CF Max Nighttime syrups. The FDA reports they can be identified by the information below:
Robitussin Honey CF Max Day – Adult 4-ounce
- Lot number: T10810
- Expiration date: October 31, 2025
Robitussin Honey CF Max Day – Adult 8-ounce
- Lot numbers: T08730, T08731, T08732, T08733, T10808
- Expiration dates:
- May 31, 2025 (T08730, T08731, T08732, T08733)
- September 20, 2025 (T10808)
Robitussin Honey CF Max NT – Adult 8-ounce
- Lot numbers: T08740, T08742
- Expiration date: June 30, 2026
10 Places You’re Most Likely to Catch the Flu, According to Infectious Disease Experts
Haleon and the FDA urge customers not to consume these products. The notice stipulates that in healthy individuals, the product isn’t likely to cause harm. However, according to the recall, immunocompromised people could experience poorer outcomes and develop fungemia or disseminated fungal infection. If anyone suspects they are having a reaction to the product, they should contact their healthcare provider for advice.
Anyone with questions can contact the company for more information at 1-800-245-1040 (Monday through Friday 8 a.m. to 6 p.m. ET) or email [email protected]. All adverse reactions should also be reported to the FDA.
Originally Published: January 24, 2024
